LYSMD4 Activators
LYSMD4 activators are largely centered on compounds that can mimic bacterial components or stimulate immune response pathways. In the first paragraph, the focus is on molecules like Muramyl Dipeptide, Lipopolysaccharide (LPS), and Pam3CSK4, which are known to trigger immune responses by mimicking bacterial components. These compounds could activate LYSMD4 by engaging the protein in immune-related signaling pathways, assuming LYSMD4's involvement in recognizing bacterial elements or modulating immune responses.
Attention is given to compounds like Poly(I:C), Flagellin, and CpG Oligodeoxynucleotides, which are known to mimic viral and bacterial molecular patterns and activate immune responses. Agonists of Toll-like receptors such as R848, Imiquimod, and Gardiquimod, by stimulating specific immune signaling pathways, could also enhance LYSMD4 activity. Zymosan, as a fungal cell wall component, and Aluminum hydroxide, used as an adjuvant, represent additional methods of indirectly activating LYSMD4 by stimulating immune responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
A component of the bacterial outer membrane, could indirectly activate LYSMD4 by stimulating immune response pathways. | ||||||
Pam3Cys-Ser-(Lys)4, Hydrochloride | 112208-00-1 | sc-507471 | 2 mg | $550.00 | ||
A synthetic lipopeptide, mimics bacterial lipoproteins and could activate LYSMD4 through Toll-like receptor pathways. | ||||||
Polyinosinic-polycytidylic acid potassium salt | 31852-29-6 | sc-202767 | 5 mg | $198.00 | ||
A synthetic analog of double-stranded RNA, could activate LYSMD4 by stimulating antiviral response pathways. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $102.00 $306.00 $510.00 $1559.00 | 12 | |
An agonist of Toll-like receptors 7 and 8, could activate LYSMD4 in immune signaling pathways. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
A Toll-like receptor 7 agonist, might activate LYSMD4 through pathways involved in innate immunity. | ||||||
Zymosan | 9010-72-4 | sc-296863 sc-296863A | 100 mg 1 g | $99.00 $599.00 | 1 | |
A β-glucan/fungal cell wall component, could activate LYSMD4 by triggering pattern recognition and immune response pathways. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $157.00 $282.00 $516.00 $1177.00 $20138.00 $32779.00 $70753.00 | 1 | |
A TLR7 agonist, potentially activating LYSMD4 through innate immune signaling pathways. | ||||||
Aluminum hydroxide | 21645-51-2 | sc-214529 sc-214529A | 100 g 500 g | $39.00 $55.00 | 3 | |
An adjuvant, could indirectly enhance LYSMD4 function by boosting immune response mechanisms. | ||||||